PubRank

S Giménez-Roldán

Author PubWeight™ 29.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dementia paralytica: deterioration from communicating hydrocephalus. J Neurol Neurosurg Psychiatry 1979 1.42
2 [Arnold-Chiari malformation with multiple paroxysmal manifestations induced by coughing]. Neurologia 1992 1.36
3 [Brain dynamics according to Justo Gonzalo]. Neurologia 2004 1.08
4 Nummular headache secondary to an intracranial mass lesion. Cephalalgia 2007 1.04
5 Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord 1992 1.01
6 Tabetic lightning pains: high-dosage intravenous penicillin versus carbamazepine therapy. Eur Neurol 1981 0.99
7 Abnormalities of Bell's phenomenon in amyotrophic lateral sclerosis: a clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry 1978 0.95
8 Sensory ataxic hemiparesis in thalamic hemorrhage. Stroke 1990 0.92
9 Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study. J Neural Transm (Vienna) 2003 0.91
10 Clinicopathological correlation in symptomatic dystonia. Adv Neurol 1988 0.91
11 Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics. Eur Neurol 1984 0.88
12 Involuntary closure of eyelids in parkinsonism. Electrophysiological evidence for prolonged inhibition of the levator palpebrae muscles. J Neurol Sci 1988 0.86
13 Autosomal dominant endosteal hyperostosis. Report of a Spanish family with neurological involvement. Clin Genet 1987 0.83
14 Familial communicating syringomyelia. J Neurol Sci 1978 0.83
15 Idiopathic torsion dystonia as described by Barraquer-Roviralta. Adv Neurol 1988 0.82
16 Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis. Acta Psychiatr Scand 1985 0.81
17 [Neurological complications of Mediterranean boutonneuse fever. Presentation of a case of acute encephalomeningomyelitis and review of the literature]. Neurologia 1999 0.80
18 Communicating syringomyelia following cured tuberculous meningitis. J Neurol Sci 1974 0.80
19 Intermediate scale for assessment of Parkinson's disease. Characteristics and structure. Parkinsonism Relat Disord 1995 0.80
20 [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements]. Neurologia 1989 0.78
21 [Palm-chin reflex in Parkinson's disease]. Arch Neurobiol (Madr) 1977 0.78
22 [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses]. Rev Neurol 2000 0.78
23 Effectiveness of clonazepan in startle-induced seizures. Epilepsia 1979 0.78
24 Early detection of Huntington's disease. Blink reflex and levodopa load in presymptomatic and incipient subjects. J Neurol Neurosurg Psychiatry 1981 0.78
25 Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. Clin Neuropharmacol 1992 0.77
26 Dementia in Idiopathic hypoparathyroidism. Rapid efficacy of alfacalcidol. Arch Neurol 1982 0.76
27 [Patient care in a hospital based unit for treating Parkinson's disease and movement disorders: a 3-year prospective study]. Neurologia 1994 0.76
28 Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study. J Neural Transm (Vienna) 2004 0.76
29 [Alzheimer's disease]. Rev Clin Esp 1995 0.75
30 [Neurocysticercosis among Latin American emigrants]. Rev Clin Esp 1990 0.75
31 [Drug-induced and masked drug parkinsonism]. Rev Neurol 1996 0.75
32 [Movement disorders in Hashimoto's encephalopathy]. Rev Neurol 2007 0.75
33 Premorbid dietetic habits and risk for Parkinson's disease. Parkinsonism Relat Disord 1997 0.75
34 [Severe dysphagia in Huntington's chorea with associated scleroderma]. Rev Clin Esp 1971 0.75
35 [Progressive supranuclear paralysis. Critical review, with a note on verbal expression disorders and action of L-dopa]. Arch Neurobiol (Madr) 1972 0.75
36 [Therapy of progressive supranuclear paralysis. Effect of methysergide and bromocriptine on various psychoneurologic and motor functions]. Rev Clin Esp 1979 0.75
37 [Communicant syringomyelia as a delayed complication of cured meningeal tuberculosis]. Rev Clin Esp 1974 0.75
38 Startle epilepsy complicating Down syndrome during adulthood. Ann Neurol 1980 0.75
39 [Generalized cortical (Van Buchem) hyperostosis]. Rev Clin Esp 1986 0.75
40 [Clinical value of the palmomental reflex in cerebral tumors]. Acta Neurol Latinoam 1976 0.75
41 [A study made on a data base of 2,471 patients with Parkinson disease and disorders of movement in Health District 1 of the autonomous region of Madrid. Observed demographic changes over 8 year-period]. Rev Neurol 2000 0.75
42 [Dopamine agonists situation in Parkinson disease]. Rev Neurol 2002 0.75
43 [Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations]. Neurologia 2007 0.75
44 [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study]. Neurologia 1996 0.75
45 [Syphilis in current neurology. 1]. Arch Neurobiol (Madr) 1969 0.75
46 [Dominant autosomal cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A review]. Neurologia 2002 0.75
47 Prognosis in hereditary amyotrophic lateral sclerosis. Arch Neurol 1977 0.75
48 Familial Alzheimer's disease presenting as levodopa-responsive parkinsonism. Adv Neurol 1987 0.75
49 Epidemiological assessment of levodopa use in Cuba: 1993-1998. Pharmacoepidemiol Drug Saf 2006 0.75
50 [Caudate hemorrhage: a frequent diagnostic error]. Rev Clin Esp 1992 0.75
51 [Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time]. Rev Clin Esp 1980 0.75
52 Lightning pains in ankylosing spondylitis: response to carbamazepine. Arch Neurol 1983 0.75
53 High-dose intravenous-penicillin in neurosyphilis: effect on intrathecal synthesis of IgG, IgM, IgA and IgD. Acta Neurol Scand 1990 0.75
54 [Flexion spasms associated with tuberous sclerosis: long-term prognosis]. Rev Clin Esp 1980 0.75
55 [Abnormal reabsorption of cerebrospinal fluid in progressive generalized paralysis. A new pathogenetic factor]. Arch Neurobiol (Madr) 1980 0.75
56 [Cerebral moya-moya disease with bilateral kidney infarction (author's transl)]. Med Clin (Barc) 1981 0.75
57 [Nociceptive reflex of the orbicularis oculi. Study in normal subjects and in peripheral facial lesions]. Arch Neurobiol (Madr) 1974 0.75
58 [Sporadic myoclonus and convulsions induced by photostimulation in Alzheimer's disease]. Actas Luso Esp Neurol Psiquiatr 1970 0.75
59 [Torsion dystonia: historical evolution with a note on the Spanish contribution]. Arch Neurobiol (Madr) 1986 0.75
60 Flail-arm variant of amyotrophic lateral sclerosis in a Spanish soccer player. Eur J Neurol 2012 0.75
61 Preclinical EEG abnormalities in subacute sclerosing panencephalitis. Neurology 1981 0.75
62 [Aggravation of Parkinson's disease after inadequate use of levodopa in controlled-release preparations]. Neurologia 1995 0.75
63 [Causes and prognosis of convulsive epileptic status. An analysis of 40 consecutive cases]. Rev Clin Esp 1974 0.75
64 [Facioscapulohumeral inflammatory myopathy: long-term prognosis and nosologic characterization]. Neurologia 1990 0.75
65 [Abnormal movements in a case of extrapontine myelinolysis. Review of the literature]. Rev Neurol 1998 0.75
66 Orbicularis oculi "myotonia" in hypothyroid myopathy. Eur Neurol 1973 0.75
67 Focal asterixis caused by a small putaminal hemorrhage. Mov Disord 1986 0.75
68 [Subclinical leukoencephalopathy caused by methotrexate]. Neurologia 1990 0.75
69 [Essential tremor in the elderly: incidence in hospital admissions for non-neurologic reasons]. Neurologia 1989 0.75
70 [Changeable aspects in the epidemiology of Parkinson disease (analysis of 262 cases during a period of 9 years]. Rev Clin Esp 1980 0.75
71 [Developing symptomatology in treated tabes dorsalis]. Rev Clin Esp 1982 0.75
72 [Frequency of neurocysticercosis at a hospital in Madrid (1980-1989)]. Arch Neurobiol (Madr) 1990 0.75
73 [Immunosuppression in subacute sclerosing panencephalitis. A controlled study on the evolutive status of cerebrospinal fluid gamma globulin]. Rev Clin Esp 1976 0.75
74 Acute myelopathy in adulthood as a delayed consequence of radiation therapy during early infancy. J Neurol 1999 0.75
75 [Familial spastic paraparesis: phenotypic variant of adrenoleukodystrophy]. Neurologia 1990 0.75
76 Dystonia in Spain: study of a Gypsy family and general survey. Adv Neurol 1976 0.75
77 [Intravenous penicillin treatment in neurosyphilis]. Arch Neurobiol (Madr) 1982 0.75
78 [Information about the diagnosis: a subjective experience of patients with multiple sclerosis and rheumatoid arthritis]. Rev Neurol 1998 0.75
79 [Multiple calcifying hemangiomas of the brain and the blue rubber bleb nevus syndrome]. Arch Neurobiol (Madr) 1983 0.75
80 [Juvenile myoclonic epilepsy: a prospective study of 13 cases]. Neurologia 1990 0.75
81 Fusiform aneurysm of the scalp: an unusual cause of focal headache in Marfan syndrome. Headache 2002 0.75
82 [Familial amyotrophic lateral sclerosis. Critic of its classification and analysis of 14 families of Spanish origin]. Rev Clin Esp 1978 0.75
83 Acetylator polymorphism in multiple sclerosis. Acta Neurol Scand 1994 0.75
84 [Indications of anticoagulants in cerebral ischemia]. Med Clin (Barc) 1987 0.75
85 [Neurosyphilis. Changes in its hospital incidence in a span of 14 years]. Rev Clin Esp 1985 0.75
86 [Transplants in Parkinson's disease: many questions awaiting answers]. Rev Clin Esp 1988 0.75